Drugs / CEP-11981
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00875264 | Sep 2007 → Jun 2011 | cancer | Cephalon | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CEP-11981 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00875264 ↗ |
| Known as | BOL-303213X | ChEMBL registry synonym — accepted as the source's own label CHEMBL2010872 ↗ |
| Action | Inhibit | “Tyrosine-protein kinase TIE-2 inhibitor” CHEMBL2010872 ↗1“CEP-11981 (kinase inhibitor)” NCT00875264 ↗ |
| Modality | Small molecule | — CHEMBL2010872 ↗ |
| Route | Oral | “treated with oral CEP-11981 once daily” NCT00875264 ↗ |
| Target | TEK | “Tyrosine-protein kinase TIE-2 inhibitor” CHEMBL2010872 ↗ |